DiscoveryBioMed, Inc. Partners with ArtusLabs, Inc. to Identify Best Practices for Handling Numerical Data

BIRMINGHAM, Ala. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (www.discoverybiomed.com) announced today that it has partnered with ArtusLabs, Inc. (www.artuslabs.com) to identify best practices for managing significant amounts of image and numerical data. ArtusLabs’ flagship product, Ensemble for Life Science, will be the platform for managing DiscoveryBioMed’s scientific data.

“Constant communication with the client and inclusion of the client in each small step of the process is essential to our services approach. In our view, Ensemble is a software program that brings added value to our client communications by adding a “social networking”

“In addition to its own internal drug discovery initiatives, DBM is currently working on behalf of more than 15 active cell engineering and drug discovery clients.” DBM’s chief executive officer Erik Schwiebert explained. “Constant communication with the client and inclusion of the client in each small step of the process is essential to our services approach. In our view, Ensemble is a software program that brings added value to our client communications by adding a “social networking” flavor to communications between our client and our company principals for each drug discovery program. Bridging communication with effective data management ensures that we’re delivering high value, seamless research for our client base while at the same time allows us to also take advantage of Ensemble for our own discovery efforts.”

Tom Barr, chief operations officer and co-director, added, “One of the benefits of Ensemble is the ability to automatically bring machine data from our ‘robot’ into the system using the mass importer. Once set up, the data is up-to-date, accessible by the project team and organized into the appropriate folder...without me ever needing to touch it.”

The goal of this partnership will be to best practices in gathering, mining and processing, and tabulating large volumes of numerical data from light-based bioassays. Robin Smith, chief executive officer and co-founder of ArtusLabs, Inc. said, “We’re excited to be working with Dr. Schwiebert and his team. Deeply understanding the drug discovery process and the data it produces is critical for ArtusLabs. Biological-based information is often ignored in the scientific data management space. It can be made up of several document types, making it difficult to associate to one project. Ensemble was designed to solve this specific problem.”

About DiscoveryBioMed, Inc.

DiscoveryBioMed is a life sciences and biotechnology company that engages in R&D and services work in cell engineering and production and drug discovery. The company is located in Innovation Depot in Birmingham. Using physiologically relevant cell culture models preferably derived from normal and diseased adult human cells and tissues, it focuses on finding therapeutic compounds for a variety of human diseases. It also applies this custom human cell-based approach to its “fee-for-service” support to researchers in allied areas and currently serves clients both locally in Alabama as well as in 8 other states in the US currently.

About ArtusLabs, Inc.

ArtusLabs is paving the way in developing web-enabled technologies for the life science industry by striving to help their customers save time, reduce infrastructure costs, and increase organization’s information retention. ArtusLabs products and services are tuned to meet the needs of today’s scientific organization.

Please visit them at the Molecular Tri-Conference Exhibit, Booth #508, February 25-26, 2009 at the Moscone Convention Center, San Francisco, CA. To learn more, please visit: www.artuslabs.com.